Transaction #19322 · Form 4 · 0001695851-25-000004
Enliven Therapeutics, Inc. · Stock award · Stock Option (right to buy)
Enliven Therapeutics, Inc. · Transacted December 11, 2025 · Filed December 12, 2025
What does this filing report?
An SEC Form 4 filing for Enliven Therapeutics, Inc. records a stock award involving Stock Option (right to buy) on December 11, 2025. The reported quantity was 875,000. The filing date is December 12, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Enliven Therapeutics, Inc.
- Company CIK
- 0001672619
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 875,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 875,000
- Ownership description
- Not reported
- SEC acceptance time
- Dec 12, 2025, 6:31 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Fair Richard A. ↗
PRESIDENT AND CEO · Director
CIK 0001695851
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 875,000
- Conversion / exercise price
- 18.77
- Exercise date
- Not reported
- Expiration date
- December 11, 2035
Filing footnotes & remarks
- F1
- 1/4th of the shares subject to the option will vest on December 11, 2026 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.